Legence Q2 revenue rises 111% to record $1.26 billion; full-year guidance raised
Legence Corp. reported record second-quarter 2026 revenue of $1.26 billion, up 110.7% from a year earlier, and raised its full-year 2026 revenue and Adjusted EBITDA guidance. The company still posted a net loss attributable to Legence of $27.8 million, or $0.37 per diluted share, after $41.1 million in goodwill and long-lived asset impairments, and its gross margin fell to 17.4% from 21.5%. For shareholders, the filing shows strong top-line growth and higher outlook alongside a wider GAAP loss and lower margins.
Key points
- Net loss attributable to Legence was $27.8 million, or $0.37 per diluted share, compared with a net loss of $5.3 million in the second quarter of 2025.
- Non-GAAP Adjusted EBITDA was $154.6 million, up 114.1% from $72.2 million a year earlier.
- Goodwill impairment of $21.6 million and long-lived asset impairment of $19.5 million were recorded in the quarter.
- Full-year 2026 revenue guidance was raised to $4.7 billion to $4.8 billion from $4.1 billion to $4.3 billion, and Adjusted EBITDA guidance to $565 million to $585 million from $470 million to $490 million.
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.